Clinical Trials Logo

Filter by:
NCT ID: NCT03228225 Recruiting - Clinical trials for Coronary Artery Disease

Tele - Cardiac Rehabilitation - Providing Secondary Prevention and Supervised Exercise Without Boundaries of Time and Space - PILOT 1

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

We aim to enroll subjects eligible to cardiac rehabilitation that are defined as low-risk according to national guidelines. We plan to gradually reduce the number of institution based CR and increase the tele monitored exercise sessions performed in the community. Stress test will be preformed before the intervention and after completing 6 month.

NCT ID: NCT03220490 Recruiting - Glaucoma Clinical Trials

Efficacy and Necessity of Time Interval Between Instillation of Two Glaucoma Eye Drops

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

According to the American Academy of Ophthalmology's Preferred Practice Pattern on Primary Open Angle Glaucoma, patients should wait five minutes between administering topical drops for intra-ocular pressure reduction. To date, no study has shown the efficacy of this waiting period. In this study, we aim to establish the clinical significance of keeping a time interval between glaucoma medications.

NCT ID: NCT03219671 Recruiting - Clinical trials for Classic Kaposi Sarcoma

Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)

Start date: April 1, 2018
Phase: Phase 2
Study type: Interventional

A Phase 2 study of nivolumab plus ipilimumab in previously treated classical Kaposi Sarcoma (CKS)

NCT ID: NCT03218579 Recruiting - Gut Microbiome Clinical Trials

Endoscopic Assessment and Prediction of Microbiome-modifying Interventions

microbiome
Start date: February 1, 2013
Phase: N/A
Study type: Interventional

The investigators would like to examine the extent of gut microbiome rehabilitation in healthy people after the consumption of antibiotics. Outcomes of probiotic treatment versus bacteriotherapy will be compared.

NCT ID: NCT03215082 Recruiting - Clinical trials for Mild Traumatic Brain Injury; Concussion

Seeing-Moving-Playing: Early Rehabilitation Utilizing Visual and Vestibular Technology Following Traumatic Brain Injury

SiMPlyRehab
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The aim of this research program is to 1) Evaluate potential problems with vision, inner ear-eye reflexes and deficits of processing eye information that occur following TBI; and 2) Evaluate treatment programs for individuals with eye and inner ear problems that persist for greater than 10 days following injury. This study will include 465 youth and young adults (aged 6-30 years old) who sustain a TBI of any severity. An initial evaluative phase using the best available technology to evaluate eye and inner ear function will be performed, and compared with typical tests that are used in the clinic. If symptoms and functional problems remain 10 days after injury, participants will be randomly placed into a treatment group (including eye movement, inner ear-eye reflex and attention exercises as per our pilot studies) or a control group (typical rehabilitation). Success will be measured in terms of return to sport (mild TBI), achievement of goals (moderate and severe TBI) and quality of life. It is expected that this program will inform clinical practice and future research leading to a treatment program in TBI that includes multiple components.

NCT ID: NCT03214289 Recruiting - Clinical trials for Stem Cell Transplant Complications

Fecal Microbiota Transplantation for Steroid Resistant and Steroid Dependent Gut Acute Graft Versus Host Disease

Start date: July 12, 2017
Phase: Phase 1
Study type: Interventional

The investigators hypothesize that perturbations in the intestinal microbiota following allogeneic hematopoietic stem cell transplantation (HSCT) are essential for the development and propagation of acute graft-versus-host disease. Therefore, modification of HSCT recipients' gut microbiota using fecal transplantation from a healthy donor could be used to treat gut acute GVHD. The study evaluates safety and feasibility of fecal microbiota transplantation with frozen capsules from healthy donors for the treatment of steroid resistant or steroid dependent acute graft-versus-host disease of the gut.

NCT ID: NCT03210610 Recruiting - FMF Clinical Trials

Colchicine Levels in the Serum of FMF (Familial Mediterranean Fever) Patients

Start date: October 19, 2017
Phase:
Study type: Observational

in this study the investigators will measure the colchicine trough levels in 80 FMF patients taking stable doses of colchicine

NCT ID: NCT03206528 Recruiting - Oxygen Saturation Clinical Trials

Clinical Evaluation of the Vital Signs Monitoring System (VSMS)

Start date: April 25, 2017
Phase: N/A
Study type: Observational

This is an observational, cohort-based, single-site, prospective study conducted in accordance with ISO 14155-1:2003 and ISO 14155-1:2011. The primary objectives are to evaluate the accuracy of the device's measurements/readings in comparison to a gold standard or standard of care patient monitor.

NCT ID: NCT03197545 Recruiting - Stress Fracture Clinical Trials

Determining the Risk of Stress Fracture in IDF Soldiers Based on SNPs Identified for Osteoporosis

Start date: June 2017
Phase: N/A
Study type: Observational

The study is a genetic historical cohort study in a military combat recruits - this study does not examine a specific treatment but rather examines a statistical link between medical history of traumatic fractures, clinical diagnosis of stress fractures and the presence of unique SNPs in subjects DNA.

NCT ID: NCT03188549 Recruiting - Clinical trials for Comparing Use of Hand Hygiene Products

Magen Haim Project - Assessing Hand Hygiene Formulas

Start date: June 15, 2017
Phase: Phase 4
Study type: Interventional

Background: Procedures of hand hygiene are an important component in prevention of cross-transmission of infections in hospitals. In recent years, hand washing with antiseptic soap (chlorhexidine) was replaced with use of alcohol-based hand rub. This change brought an increase in compliance with hand hygiene regulations from 30-40% to over 50%, and in other places up to 70%. However, even 70% compliance is not enough. One of the reported reasons for lack of compliance of staff to the use of alcohol-based preparations is skin irritation and dryness of the hands as a result of frequent use. At Sheba, like the majority of Israeli hospitals, the product used for handwashing is Septol (Teva), which includes 0.5% chlorhexidine gluconate (CHG) and 70% ethyl alcohol. The CDC, WHO and FDA guidelines approve for use of hospital hand hygiene, products that contain between 61-85% ethanol. The investigators will replace the Septol currently used with a different alcohol-based antiseptic that is more user-friendly, and aim to determine whether this will increase the compliance with hand hygiene protocols. The investigators will assess 1. Satisfaction of staff. 2. Increase of hand hygiene compliance.